Works matching IS 13479032 AND DT 2021 AND VI 112


Results: 480
    1

    CORRECTION.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5134, doi. 10.1111/cas.15203
    Publication type:
    Article
    2
    3

    Erratum.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5133, doi. 10.1111/cas.15201
    Publication type:
    Article
    4
    5
    6

    Reviewers.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5127, doi. 10.1111/cas.15192
    Publication type:
    Article
    7
    8

    Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5034, doi. 10.1111/cas.15163
    By:
    • Shimazu, Yutaka;
    • Mizuno, Shohei;
    • Fuchida, Shin‐ichi;
    • Suzuki, Kazuhito;
    • Tsukada, Nobuhiro;
    • Hanagaishi, Akira;
    • Itagaki, Mitsuhiro;
    • Kataoka, Keisuke;
    • Kako, Shinichi;
    • Sakaida, Emiko;
    • Yoshioka, Satoshi;
    • Iida, Shinsuke;
    • Doki, Noriko;
    • Oyake, Tatsuo;
    • Ichinohe, Tatsuo;
    • Kanda, Yoshinobu;
    • Astuta, Yoshiko;
    • Takamatsu, Hiroyuki
    Publication type:
    Article
    9
    10
    11
    12

    HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5011, doi. 10.1111/cas.15158
    By:
    • Ri, Masaki;
    • Iida, Shinsuke;
    • Maruyama, Dai;
    • Sakabe, Aya;
    • Kamei, Ryo;
    • Nakashima, Takuto;
    • Tohkin, Masahiro;
    • Osaga, Satoshi;
    • Tobinai, Kensei;
    • Fukuhara, Noriko;
    • Miyazaki, Kana;
    • Tsukamoto, Norifumi;
    • Tsujimura, Hideki;
    • Yoshimitsu, Makoto;
    • Miyamoto, Kenichi;
    • Tsukasaki, Kunihiro;
    • Nagai, Hirokazu
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    A STING inhibitor suppresses EBV‐induced B cell transformation and lymphomagenesis.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5088, doi. 10.1111/cas.15152
    By:
    • Miyagi, Shouhei;
    • Watanabe, Takahiro;
    • Hara, Yuya;
    • Arata, Masataka;
    • Uddin, Md. Kamal;
    • Mantoku, Keisuke;
    • Sago, Ken;
    • Yanagi, Yusuke;
    • Suzuki, Takeshi;
    • Masud, H. M. Abdullah Al;
    • Kawada, Jun‐ichi;
    • Nakamura, Shigeo;
    • Miyake, Yasuyuki;
    • Sato, Yoshitaka;
    • Murata, Takayuki;
    • Kimura, Hiroshi
    Publication type:
    Article
    20
    21
    22
    23

    Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5020, doi. 10.1111/cas.15153
    By:
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Kagawa, Naoki;
    • Asai, Katsunori;
    • Nagane, Motoo;
    • Matsuda, Masahide;
    • Ueki, Keisuke;
    • Kuroda, Junichiro;
    • Date, Isao;
    • Kobayashi, Hiroyuki;
    • Kumabe, Toshihiro;
    • Beppu, Takaaki;
    • Kanamori, Masayuki;
    • Kasai, Shota;
    • Nishimura, Yasuko;
    • Xiong, Hao;
    • Ocampo, Christopher;
    • Yamada, Masakazu;
    • Mishima, Kazuhiko
    Publication type:
    Article
    24
    25
    26
    27
    28

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    29

    Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4669, doi. 10.1111/cas.15092
    By:
    • Satoru Iwasa;
    • Kei Muro;
    • Satoshi Morita;
    • Young Suk Park;
    • Masato Nakamura;
    • Masahito Kotaka;
    • Tomohiro Nishina;
    • Hiroshi Matsuoka;
    • Joong Bae Ahn;
    • Keun-Wook Lee;
    • Yong Sang Hong;
    • Sae Won Han;
    • Sang-Hee Cho;
    • Dong-Sheng Zhang;
    • Wei-Jia Fang;
    • Li Bai;
    • Xiang-Lin Yuan;
    • Ying Yuan;
    • Yasuhide Yamada;
    • Junichi Sakamoto
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Issue Information.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 4813, doi. 10.1111/cas.14481
    Publication type:
    Article
    36
    37
    38

    Issue Information.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4419, doi. 10.1111/cas.14479
    Publication type:
    Article
    39

    Correction.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4812, doi. 10.1111/cas.15148
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50